Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.04
LHCG's Cash-to-Debt is ranked lower than
84% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 0.26 vs. LHCG: 0.04 )
Ranked among companies with meaningful Cash-to-Debt only.
LHCG' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.55 Max: No Debt
Current: 0.04
Equity-to-Asset 0.64
LHCG's Equity-to-Asset is ranked higher than
76% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. LHCG: 0.64 )
Ranked among companies with meaningful Equity-to-Asset only.
LHCG' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.04  Med: 0.68 Max: 0.82
Current: 0.64
-0.04
0.82
Interest Coverage 24.03
LHCG's Interest Coverage is ranked higher than
70% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 7.25 vs. LHCG: 24.03 )
Ranked among companies with meaningful Interest Coverage only.
LHCG' s Interest Coverage Range Over the Past 10 Years
Min: 18.3  Med: 35.04 Max: 713.45
Current: 24.03
18.3
713.45
Piotroski F-Score: 4
Altman Z-Score: 5.22
Beneish M-Score: -2.53
WACC vs ROIC
8.20%
10.22%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 7.71
LHCG's Operating Margin % is ranked higher than
55% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 6.49 vs. LHCG: 7.71 )
Ranked among companies with meaningful Operating Margin % only.
LHCG' s Operating Margin % Range Over the Past 10 Years
Min: -1.01  Med: 8.33 Max: 15.99
Current: 7.71
-1.01
15.99
Net Margin % 4.00
LHCG's Net Margin % is ranked higher than
50% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. LHCG: 4.00 )
Ranked among companies with meaningful Net Margin % only.
LHCG' s Net Margin % Range Over the Past 10 Years
Min: -2.09  Med: 4.15 Max: 10.95
Current: 4
-2.09
10.95
ROE % 9.78
LHCG's ROE % is ranked higher than
53% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. LHCG: 9.78 )
Ranked among companies with meaningful ROE % only.
LHCG' s ROE % Range Over the Past 10 Years
Min: -4.93  Med: 10.04 Max: 26.16
Current: 9.78
-4.93
26.16
ROA % 6.11
LHCG's ROA % is ranked higher than
67% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 3.51 vs. LHCG: 6.11 )
Ranked among companies with meaningful ROA % only.
LHCG' s ROA % Range Over the Past 10 Years
Min: -3.51  Med: 6.61 Max: 20.02
Current: 6.11
-3.51
20.02
ROC (Joel Greenblatt) % 68.73
LHCG's ROC (Joel Greenblatt) % is ranked higher than
84% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 15.74 vs. LHCG: 68.73 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
LHCG' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -4.82  Med: 63.16 Max: 147.21
Current: 68.73
-4.82
147.21
3-Year Revenue Growth Rate 10.40
LHCG's 3-Year Revenue Growth Rate is ranked higher than
61% of the 178 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. LHCG: 10.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
LHCG' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 3.5  Med: 20.5 Max: 60.7
Current: 10.4
3.5
60.7
3-Year EBITDA Growth Rate 13.40
LHCG's 3-Year EBITDA Growth Rate is ranked higher than
66% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. LHCG: 13.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
LHCG' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -64.8  Med: 28.7 Max: 171.3
Current: 13.4
-64.8
171.3
3-Year EPS without NRI Growth Rate 16.80
LHCG's 3-Year EPS without NRI Growth Rate is ranked higher than
65% of the 132 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. LHCG: 16.80 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
LHCG' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -21.4  Med: 24.8 Max: 112.8
Current: 16.8
-21.4
112.8
GuruFocus has detected 4 Warning Signs with LHC Group Inc $LHCG.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» LHCG's 10-Y Financials

Financials (Next Earnings Date: 2017-06-08 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

LHCG Guru Trades in Q1 2016

Paul Tudor Jones 9,200 sh (New)
Jim Simons 299,500 sh (+43.10%)
Steven Cohen 42,100 sh (-44.31%)
Joel Greenblatt 11,887 sh (-77.28%)
» More
Q2 2016

LHCG Guru Trades in Q2 2016

Joel Greenblatt 38,935 sh (+227.54%)
Paul Tudor Jones Sold Out
Steven Cohen 31,700 sh (-24.70%)
Jim Simons 122,300 sh (-59.17%)
» More
Q3 2016

LHCG Guru Trades in Q3 2016

Paul Tudor Jones 6,900 sh (New)
Steven Cohen 44,900 sh (+41.64%)
Jim Simons 172,000 sh (+40.64%)
Joel Greenblatt 15,563 sh (-60.03%)
» More
Q4 2016

LHCG Guru Trades in Q4 2016

Steven Cohen 112,000 sh (+149.44%)
Paul Tudor Jones 8,390 sh (+21.59%)
Joel Greenblatt 12,915 sh (-17.01%)
Jim Simons 91,600 sh (-46.74%)
» More
» Details

Insider Trades

Latest Guru Trades with LHCG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621610    SIC: 8082
Compare:NYSE:USPH, NAS:SGRY, NYSE:CYH, NAS:PAHC, NAS:TVTY, NAS:AFAM, OTCPK:COLRF, NAS:PRSC, OTCPK:RLGHF, OTCPK:MFCSF, NAS:ADUS, NAS:BIOS, NYSE:QHC, NYSE:CCM, NYSE:AAC, AMEX:HLTH, NYSE:SEM, NAS:AMED, OTCPK:MIHI, OTCPK:RAFLF » details
Traded in other countries:LH6.Germany,
LHC Group Inc provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies and long-term acute care hospitals.

LHC Group Inc was incorporated on February 9, 2005. The Company provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies and long-term acute care hospitals (LTACHs). The Company through its wholly- and majority-owned subsidiaries, equity joint ventures and controlled affiliates, operates in 30 states within the continental United States. The Company operates in three segments: home-based services, hospice services and facility-based services. In the home-based services segment, the Company provides home-based post-acute health care services through its home nursing and community-based agencies. Its service locations offer services, including skilled nursing, community-based nursing and companion services, non-skilled community-based services (CBS), medically-oriented social services and physical, occupational and speech therapy. The hospices segment provides end-of-life care to patients with terminal illnesses through interdisciplinary teams of physicians, nurses, home health aides, counselors and volunteers. It offers services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The LTACH locations provide services to patients with complex medical conditions who have transitioned out of a hospital intensive care unit but whose conditions remain too severe for treatment in a non-acute setting. The Company is subject to federal, state and local laws, which significantly affects its business.

Top Ranked Articles about LHC Group Inc

Stocks Steven Cohen Continues to Buy The investor purchased shares of these companies during the last 2 quarters
Steven Cohen (Trades, Portfolio), a billionaire hedge fund investor, is the founder of SAC Capital Advisors, a Stamford, Connecticut-based hedge fund that he continues to manage. He manages a portfolio composed of 668 stocks with a total value of $14.303 billion. In both the fourth and third quarters of 2016 the guru bought shares in the following stocks: Read more...
Gurus' Stocks With Negative 3 Months Returns Worst-performing stocks in gurus' portfolios
While gurus are still holding stakes in these companies, the prices of the stocks and returns of the investors are dropping. These are the worst-performing stocks over the last six months that have a long-lasting presence in more than four gurus’ portfolio. Read more...

Ratios

vs
industry
vs
history
PE Ratio 24.17
LHCG's PE Ratio is ranked higher than
58% of the 247 Companies
in the Global Medical Care industry.

( Industry Median: 27.32 vs. LHCG: 24.17 )
Ranked among companies with meaningful PE Ratio only.
LHCG' s PE Ratio Range Over the Past 10 Years
Min: 7.61  Med: 18.51 Max: 32.35
Current: 24.17
7.61
32.35
Forward PE Ratio 23.36
LHCG's Forward PE Ratio is ranked lower than
61% of the 83 Companies
in the Global Medical Care industry.

( Industry Median: 19.61 vs. LHCG: 23.36 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 24.17
LHCG's PE Ratio without NRI is ranked higher than
57% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 27.32 vs. LHCG: 24.17 )
Ranked among companies with meaningful PE Ratio without NRI only.
LHCG' s PE Ratio without NRI Range Over the Past 10 Years
Min: 7.62  Med: 18.33 Max: 32.35
Current: 24.17
7.62
32.35
Price-to-Owner-Earnings 32.54
LHCG's Price-to-Owner-Earnings is ranked lower than
58% of the 93 Companies
in the Global Medical Care industry.

( Industry Median: 27.69 vs. LHCG: 32.54 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
LHCG' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.64  Med: 19.51 Max: 74.26
Current: 32.54
6.64
74.26
PB Ratio 2.24
LHCG's PB Ratio is ranked higher than
53% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 2.28 vs. LHCG: 2.24 )
Ranked among companies with meaningful PB Ratio only.
LHCG' s PB Ratio Range Over the Past 10 Years
Min: 0.88  Med: 1.95 Max: 4.51
Current: 2.24
0.88
4.51
PS Ratio 0.97
LHCG's PS Ratio is ranked higher than
65% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.49 vs. LHCG: 0.97 )
Ranked among companies with meaningful PS Ratio only.
LHCG' s PS Ratio Range Over the Past 10 Years
Min: 0.35  Med: 0.84 Max: 2.33
Current: 0.97
0.35
2.33
Price-to-Free-Cash-Flow 17.18
LHCG's Price-to-Free-Cash-Flow is ranked higher than
68% of the 114 Companies
in the Global Medical Care industry.

( Industry Median: 23.68 vs. LHCG: 17.18 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
LHCG' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.89  Med: 12.84 Max: 75.65
Current: 17.18
3.89
75.65
Price-to-Operating-Cash-Flow 13.09
LHCG's Price-to-Operating-Cash-Flow is ranked higher than
53% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 13.47 vs. LHCG: 13.09 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
LHCG' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.67  Med: 10.09 Max: 146.83
Current: 13.09
3.67
146.83
EV-to-EBIT 14.06
LHCG's EV-to-EBIT is ranked higher than
70% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 19.61 vs. LHCG: 14.06 )
Ranked among companies with meaningful EV-to-EBIT only.
LHCG' s EV-to-EBIT Range Over the Past 10 Years
Min: -80.8  Med: 9.6 Max: 94.9
Current: 14.06
-80.8
94.9
EV-to-EBITDA 12.02
LHCG's EV-to-EBITDA is ranked higher than
65% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 14.29 vs. LHCG: 12.02 )
Ranked among companies with meaningful EV-to-EBITDA only.
LHCG' s EV-to-EBITDA Range Over the Past 10 Years
Min: -74.8  Med: 8.8 Max: 137.5
Current: 12.02
-74.8
137.5
PEG Ratio 0.37
LHCG's PEG Ratio is ranked higher than
97% of the 89 Companies
in the Global Medical Care industry.

( Industry Median: 3.12 vs. LHCG: 0.37 )
Ranked among companies with meaningful PEG Ratio only.
LHCG' s PEG Ratio Range Over the Past 10 Years
Min: 0.26  Med: 0.37 Max: 0.61
Current: 0.37
0.26
0.61
Shiller PE Ratio 30.63
LHCG's Shiller PE Ratio is ranked lower than
56% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 28.74 vs. LHCG: 30.63 )
Ranked among companies with meaningful Shiller PE Ratio only.
LHCG' s Shiller PE Ratio Range Over the Past 10 Years
Min: 13.9  Med: 22.54 Max: 33.85
Current: 30.63
13.9
33.85
Current Ratio 1.86
LHCG's Current Ratio is ranked higher than
73% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. LHCG: 1.86 )
Ranked among companies with meaningful Current Ratio only.
LHCG' s Current Ratio Range Over the Past 10 Years
Min: 1.65  Med: 2.19 Max: 4.17
Current: 1.86
1.65
4.17
Quick Ratio 1.86
LHCG's Quick Ratio is ranked higher than
76% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.16 vs. LHCG: 1.86 )
Ranked among companies with meaningful Quick Ratio only.
LHCG' s Quick Ratio Range Over the Past 10 Years
Min: 1.65  Med: 2.19 Max: 4.17
Current: 1.86
1.65
4.17
Days Sales Outstanding 49.79
LHCG's Days Sales Outstanding is ranked lower than
60% of the 174 Companies
in the Global Medical Care industry.

( Industry Median: 44.22 vs. LHCG: 49.79 )
Ranked among companies with meaningful Days Sales Outstanding only.
LHCG' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.2  Med: 49.57 Max: 85.77
Current: 49.79
46.2
85.77

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -0.90
LHCG's 3-Year Average Share Buyback Ratio is ranked higher than
67% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. LHCG: -0.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
LHCG' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13.5  Med: -0.7 Max: 2
Current: -0.9
-13.5
2

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.24
LHCG's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
72% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.79 vs. LHCG: 1.24 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
LHCG' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.34  Med: 0.74 Max: 1.26
Current: 1.24
0.34
1.26
Price-to-Median-PS-Value 1.15
LHCG's Price-to-Median-PS-Value is ranked lower than
59% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 1.05 vs. LHCG: 1.15 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
LHCG' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.44  Med: 1.11 Max: 2.64
Current: 1.15
0.44
2.64
Earnings Yield (Greenblatt) % 7.09
LHCG's Earnings Yield (Greenblatt) % is ranked higher than
76% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 3.94 vs. LHCG: 7.09 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
LHCG' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 1.1  Med: 9.9 Max: 25.9
Current: 7.09
1.1
25.9
Forward Rate of Return (Yacktman) % -18.18
LHCG's Forward Rate of Return (Yacktman) % is ranked lower than
90% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 10.02 vs. LHCG: -18.18 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
LHCG' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -6223.3  Med: 12.95 Max: 28946.6
Current: -18.18
-6223.3
28946.6

More Statistics

Revenue (TTM) (Mil) $914.8
EPS (TTM) $ 2.07
Beta0.84
Short Percentage of Float3.89%
52-Week Range $32.04 - 54.11
Shares Outstanding (Mil)18.15

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 1,012 1,094
EPS ($) 2.16 2.40
EPS without NRI ($) 2.16 2.40
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.00%
Dividends per Share ($)
» More Articles for LHCG

Headlines

Articles On GuruFocus.com
Gurus' Stocks With Negative 3 Months Returns Aug 11 2016 
Intelligent (and Unintelligent) Investing: Part 1 Jun 03 2015 
“Powerball” Ideas - Home Healthcare Companies: AFAM, GTIV, LHCG, AMED Jan 05 2012 
LHC Group Reports Operating Results (10-K) Mar 10 2011 
LHC Group Reports Operating Results (10-Q) Nov 03 2010 
LHC Group Reports Operating Results (10-Q) Aug 06 2010 
LHC Group (LHCG) CFO Peter J. Roman sells 1,200 Shares May 27 2010 
LHC Group (LHCG) CEO and President, 10% Owner Keith G Myers sells 169,800 Shares May 13 2010 
LHC Group (LHCG) CEO and President, 10% Owner Keith G Myers sells 5,200 Shares May 12 2010 
A Simple Metric to Clarify the Balance Sheet Apr 19 2010 

More From Other Websites
LHC Group to Present at Oppenheimer 27th Annual Healthcare Conference Mar 20 2017
LHC GROUP, INC Financials Mar 15 2017
Correction: Earns-LHC Group story Mar 13 2017
Correction: Earns-LHC Group story Mar 13 2017
LHC Group upgraded by SunTrust and RBC Capital Mkts Mar 10 2017
Edited Transcript of LHCG earnings conference call or presentation 9-Mar-17 4:00pm GMT Mar 09 2017
LHC GROUP, INC Files SEC form 10-K, Annual Report Mar 09 2017
LHC Group, Inc. :LHCG-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017 Mar 09 2017
LHC Group Reports Fourth-Quarter 2016 EPS of $0.55 and Adjusted EPS of $0.58 on Revenue of $235.4... Mar 08 2017
Q4 2016 LHC Group Inc Earnings Release - After Market Close Mar 08 2017
Stocks Steven Cohen Continues to Buy Mar 02 2017
LHC Group Announces Fourth Quarter and Year-End 2016 Earnings Release and Conference Call Dates Feb 22 2017
LHC Group to Present at RBC Capital Markets 2017 Healthcare Conference Feb 15 2017
LHC Group to Present at 35th Annual J.P. Morgan Healthcare Conference Jan 05 2017
Tuscumbia hospice nurse named to AHPCO 2017 executive board Jan 03 2017
LHC Group and LifePoint Health collaborate to enhance home health and hospice services nationwide Jan 03 2017
LHC Group and LifePoint Health Collaborate to Enhance Home Health and Hospice Services Nationwide Jan 03 2017
Neogen (NEOG) Acquires Brazilian Private Company Rogama Dec 28 2016
Patterson and ADPI Extend Partnership for Dental Platform Dec 27 2016
Mazor Robotics Receives Order for Three Mazor X Systems Dec 27 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)